内皮糖蛋白
血管生成拟态
CD146号
医学
川地31
危险系数
内科学
免疫组织化学
生存分析
肿瘤科
病理
微血管
比例危险模型
单变量分析
置信区间
多元分析
癌症
生物
川地34
转移
遗传学
干细胞
作者
Д. А. Зиновкин,Hongbo Wang,Zhicheng Yu,Qian Zhang,Yang Zhang,Sitian Wei,Ting Zhou,Qi Zhang,Jun Zhang,Э. А. Надыров,A. Farooq,Yu. A. Lyzikova,Ilya V. Vejalkin,Irina I. Slepokurova,Md Zahidul Islam Pranjol
出处
期刊:Biomarkers
[Informa]
日期:2024-10-02
卷期号:29 (7): 459-465
标识
DOI:10.1080/1354750x.2024.2415078
摘要
The microvessel compartment is crucial in the tumor microenvironment of endometrioid adenocarcinoma (EA). This study investigated the role of vasculogenic mimicry (VM), CD146, and CD105 microvessel density in the clinical prognosis of EA. A total of 188 EA cases were analyzed, with VM channels and microvessels detected using PAS/CD31, CD146, and CD105 staining. Mann-Whitney and Fisher exact tests were used to compare the study groups according to the evaluated criteria. ROC analysis included determination of the confidence interval (CI) and area under the ROC curve. The Mantel-Cox test was used to analyze progression-free survival. Multivariate Cox proportional hazard analysis was performed using stepwise regression. Results showed that VM channels and CD146 and CD105 microvessels were significantly higher (p < 0.0001) in cases with unfavorable prognosis. Univariate survival analysis highlighted the significant role of these factors in progression-free survival, while multivariate Cox analysis identified VM and CD146+ vessels as predictive factors. This study demonstrates, for the first time, that VM, CD146, and CD105-positive vessels are involved in EA prognosis, suggesting their potential as independent prognostic indicators and targets for antiangiogenic therapy. However, these findings require further validation through large-scale studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI